Ascom Announces Ascom Myco 3 Smartphone Approved for the Target Platform for Epic Rover

Ascom calls listing “yet another exciting step forward” for its
flagship healthcare mobile device

RALEIGH, N.C.–(BUSINESS WIRE)–Ascom, the global solutions provider focused on healthcare ICT and
mobile workflow solutions, has announced that the Ascom Myco™ 3
smartphone has been listed on the Target Platform for the Epic Rover
healthcare application. The app gives clinical users of Epic’s
Electronic Health Record access to tools for clinical review, medication
administration, specimen collection, and other clinical documentation
workflows right from their mobile devices.

Part of the Ascom Healthcare Platform, the Ascom Myco 3 smartphone is
available in cellular and Wi-Fi versions. Running on the Android™ 8.1
OS, the device features a HD 5” touchscreen, an integrated
enterprise-grade barcode scanner, NFC functionality and a true
hot-swappable battery. It works together with Ascom and third-party
software and apps to put context-rich information from multiple sources
into the hands of highly mobile clinicians. Designed for clinical and
other demanding environments, the Ascom Myco 3 combines a robust yet
ergonomic form with advanced integration capabilities and
enterprise-grade security features.

For Ascom Chief Sales and Marketing Officer Francis Schmeer, the listing
is, “yet another exciting step forward for the Ascom Myco 3 smartphone.”
The device works with apps such as Rover to connect clinicians to
patient data, colleagues and IT systems—helping to streamline workflows,
boost productivity and ultimately contribute to enhanced patient
satisfaction and outcomes.

Schmeer also points to the app’s interoperability with the Ascom Myco 3
embedded barcode scanner as an example of how the smartphone enables
mobile functionality for clinicians. “The Ascom Myco 3 barcode scanner
lets clinicians securely identify patients, medications and colleagues
at the point of care and while on the go. It’s a clear illustration of
how the smartphone benefits busy clinicians, enabling smooth access to
key data, and the ability to communicate and coordinate with colleagues,
systems and patients.”

Epic and Rover are registered trademarks of Epic Systems Corporation.

Android is a trademark of Google LLC.

About Ascom

Ascom is a global solutions provider focused on healthcare ICT and
mobile workflow solutions. The vision of Ascom is to close digital
information gaps allowing for the best possible decisions – anytime and
anywhere. Ascom’s mission is to provide mission-critical, real-time
solutions for highly mobile, ad hoc, and time-sensitive environments.
Ascom uses its unique product and solutions portfolio and software
architecture capabilities to devise integration and mobilization
solutions that provide truly smooth, complete, and efficient workflows
for healthcare as well as for industry and retail sectors.

Ascom is headquartered in Baar (Switzerland), has operating businesses
in 18 countries and employs around 1,300 people worldwide. Ascom
registered shares (ASCN) are listed on the SIX Swiss Exchange in Zurich.

Contacts

Chris Talbot
Senior Vice President, Marketing & Business Development
Ascom
North America
+1-919-234-2465
chris.talbot@ascom.com

Staff

Recent Posts

Teknova Announces Closing of $15.4 Million Private Placement

HOLLISTER, Calif., July 12, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a…

1 day ago

Faith In Young Champions: Hisense Partners with UEFA Foundation to Bring the Beautiful Game to Hospitalized Children

QINGDAO, China, July 12, 2024 /PRNewswire/ -- During the EURO 2024 tournament, the global home…

2 days ago

JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA CORPORATION AND NEW TICKER SYMBOL TO ALTS

LAS VEGAS, July 12, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with…

2 days ago

Hospital Español Auxilio Mutuo De Puerto Rico, Inc. Reports Network Breach

Important Notice About a Privacy MatterSAN JUAN, PUERTO RICO / ACCESSWIRE / July 12, 2024…

2 days ago

Nano Labs Announces Receipt of Deficiency Letters from Nasdaq

HANGZHOU, China, July 12, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or…

2 days ago

Inhance Technologies’ Statement in Response to EPA’s Section 6 Approach on Fluorination of Plastic Containers

HOUSTON, July 12, 2024 /PRNewswire/ -- Inhance Technologies welcomes the opportunity to engage with the…

2 days ago